Disruption of Dicer1 Induces Dysregulated Fetal Gene Expression and Promotes Hepatocarcinogenesis
Background & Aims
Growing evidence suggests that microRNAs coordinate various biological processes in the liver. We describe experiments to address the physiologic roles of these new regulators of gene expression in the liver that are as of yet largely undefined.
Methods
We disrupted Dicer, an enzyme essential for the processing of microRNAs, in hepatocytes using a conditional knockout mouse model to elucidate the consequences of loss of microRNAs.
Results
The conditional knockout mouse livers showed the efficient disruption of Dicer1 at 3 weeks after birth. This resulted in prominent steatosis and the depletion of glycogen storage. Dicer1-deficient liver exhibited increased growth-promoting gene expression and the robust expression of fetal stage–specific genes. The consequence of Dicer elimination included both increased hepatocyte proliferation and overwhelming apoptosis. Over time, Dicer1-expressing wild-type hepatocytes that had escaped Cre-mediated recombination progressively repopulated the entire liver. Unexpectedly, however, two thirds of the mutant mice spontaneously developed hepatocellular carcinomas derived from residual Dicer1-deficient hepatocytes at 1 year of age.
Conclusions
Dicer and microRNAs have critical roles in hepatocyte survival, metabolism, developmental gene regulation, and tumor suppression in the liver. Loss of Dicer primarily impairs hepatocyte survival but can promote hepatocarcinogenesis in cooperation with additional oncogenic stimuli.
Abbreviation used in this paper: PCR, polymerase chain reaction
To access this article, please choose from the options below
Conflicts of interest The authors disclose no conflicts.
Funding Supported by a Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan, as well as a program for promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio), Japan. Work in M.H.'s laboratory was supported by a grant from the National Institutes of Health (CA112537).
PII: S0016-5085(09)00353-9
doi:10.1053/j.gastro.2009.02.067
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.

